Advertisement
The securities described above were offered by Jazz Pharmaceuticalspursuant to a registration statement previously filed and declared effectiveby the Securities and Exchange Commission (the "SEC").
Advertisement
This press release shall not constitute an offer to sell or thesolicitation of an offer to buy, nor shall there be any sale of thesesecurities in any state or jurisdiction in which such offer, solicitation orsale would be unlawful prior to registration or qualification under thesecurities laws of any such state. The securities may be offered only by meansof a prospectus. Copies of the final prospectus supplement and accompanyingbase prospectus relating to this offering may be obtained at the SEC's websiteat http://www.sec.gov or from Lazard Capital Markets LLC at 30 RockefellerPlaza, 60th Floor, New York, NY, 10020.
About Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals, Inc. is a specialty pharmaceutical company focusedon identifying, developing and commercializing innovative products to meetunmet medical needs in neurology and psychiatry. For further information,please visit http://www.JazzPharmaceuticals.com.
SOURCE Jazz Pharmaceuticals, Inc.
